Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

BACKGROUND: Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs). METHODS: In a randomized controlled study in adults, we compared treatment with es...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: DiMango, Emily, Walker, Patricia, Keating, Claire, Berdella, Maria, Robinson, Newell, Langfelder-Schwind, Elinor, Levy, Diane, Liu, Xinhua
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3931289/
https://ncbi.nlm.nih.gov/pubmed/24528942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-21
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items